January 21, 2019 6:22am


RMi is the source investors and traders need – it’s more than opinion; the facts and truth need to be recognized!

I post about “indication intelligence” devoting my time to collection and analysis of information for insight into sector vulnerabilities and strengths.


My writing is “that warning analysis is NOT a commodity.

However, there are times, when the likelihood of conclusions are inescapable!





Our hit/miss batting average well exceeds ... 82%. 


Can you do better elsewhere?


THE reason to subscribe to RMi …it’s been a choppy year!


Volatility, news. rumors and "runways" i.e. cash positions along with who needs to “tap” the capital markets for continued survival? 

How are enrollments going as to population and are they sustainable re drop-outs?

Has the data from on-going trials been interpreted as to render measureable and definitive outcomes? Is the company partnered to ward-off the issues of dilution and share depreciation!


And finally, trend analysis – does momentum’s magnitude, technicals and fundamentals indicate expected pricing performance in 2019?

Why spend time finding sector news and analytics … it’s all right here! Review daily indicators, factors and trend lines, advance/decline lines, pre-open indicator results and volatility and of the % count of decliners versus gainers.


Learn who is stumbling and what the mumbling means …


SUBSCRIBE ... for continued access to what one industry CEO calls the “Bible” for smart investing in the RegMed, gene and cell therapy sector

Click on the BUY button: http://www.regmedinvestors.com/create-account    


My motto: Never leave an investor uninformed!